Scholars Central

Conference abstractPublished 14 May 2018

Evaluation of the tolerance of a new Metronidazole-based oral suspension in puppies

Authors: Nicolas Celine, Ayadi N

Virbac, France

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

The objective of this study was to evaluate the tolerance of a new metronidazole-based oral suspension (EradiaâÂ?¢, Virbac) following daily administration to beagle puppies (aound 12 weeks old). Three groups of 8 dogs received either one (1X), two (2X) or three (3X) times the recommended therapeutic dose (25 mg/kg BW, twice a day) for three times the duration of treatment (i.e. 15 consecutive days). Another group received five (5X) times the therapeutic dose for the intended duration of treatment (i.e. 5 consecutive days) and another group was used as control (placebo). A clinical examination and body weight recording were performed on pre-test and on days 1, 6, 11 and 16. The amount of food and water consumed was recorded daily. Blood and urine were collected on pre-test and on day 16 for hematology, blood biochemistry (including C-reactive protein levels) and urinary investigations. On completion, the animals were sacrificed and a full macroscopic and microscopic post-mortem examination was performed. No unscheduled deaths occurred and no clinical signs of toxicological importance were observed at any dose-level. No drug-related observations were recorded and body weight, food and water consumption were unaffected. At laboratory investigations (hematology, blood biochemistry, C-reactive protein levels and urinalysis), no drug-related changes were noted. Finally, no organ weight changes and no macroscopic or microscopic findings related to the treatment were observed. Therefore, EradiaâÂ?¢ was well tolerated by puppies up to 3X the dose for 15 days or at 5X the dose for 5 days.

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

More from this journal

The newest in Journal of Clinical Trials.

All its articles

Conferences in this field

Upcoming conferences in this field.

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalJournal of Clinical Trials
  • SubjectPharmaceutical Sciences
  • BylineArticles whose byline prints “Nicolas Celine”
  • BylineArticles whose byline prints “Ayadi N”